TORONTO (CP) - Ranbaxy Laboratories of India said Thursday it will appeal a Canadian court decision holding back Ranbaxy from launching a generic competitor to Pfizer Inc.'s Lipitor cholesterol drug.
FULL STORY

Source: Canadian Online Health News